Sam is a trader and one of our lead stock analysts at AskTraders. After starting his career predominantly in the forex markets, Sam now focuses on gold and stocks with a preference for macroeconomic analysis.
Shares of Auris Medical (NASDAQ: EARS) exploded over 480% higher today, closing the day at $5.20, +368.47% after the company reported positive efficacy data for its AM-301 nasal spray in protecting against COVID-19 infections.
“Daily treatment with AM-301, beginning right before inoculation, showed effective protection against viral infection. 48 hours post-infection, average virus titers were 90.0% lower than those observed in controls (p<0.05). 72 hours and 96 hours post-infection, average virus titers were 99.2 and 99.4% lower, respectively.”
Biopharmaceutical company, Minerve Neurosciences (NASDAQ: NERV) shares are down over 23% on Tuesday after the company announced the outcome of its Type C meeting with the US Food and Drug Administration (FDA).
Shares of Virgin Galactic (NYSE: SPCE) are up 5.37% on Tuesday at $28.04 after NASA said it has selected the company to provide flight and integration services for payloads chosen by the agency’s Flight Opportunities Program.
FTSE 100 +1.91%
STOXX 50 +0.97%
IBEX 35 +0.76%
CAC 40 +1.14%
NIO revealed that it delivered 5,291 vehicles in November, a rise of 109.3% year over year and a new monthly record for the company, beating its previous record from last month which was 5,055 vehicles delivered in October.
Despite the headline, NIO shares have fallen since the open and are now down 2% at $49.52.
BlackBerry and Amazon have teamed up and developed a cloud-based software platform designed to help automakers and suppliers standardise vehicle data in speed up the deployment of revenue-generating features and services,
BlackBerry (BB) +32%
Amazon (AMZN) +0.40%
Shares of Tiziana Life Sciences PLC (LON: TILS) surged 10.7% today after the company announced that its CEO would host an investor update call on Wednesday 2, December. Investors seem to be expecting a positive report tomorrow given today’s rally.
F-Star Therapeutics shares are up 28.31% premarket at $9.02 after GlaxoSmithKline reported an 8.9% passive stake in the company.
Shares of exhibition and conference organiser Hyve Group (LON: HYVE) are up over 18% on Tuesday after the company released its results for the fiscal year ending September 30th.
FTSE 100 +0.49%
STOXX 50 +0.57%
IBEX 35 +0.55%
CAC 40 +0.56%
Following the move lower on Wall Street yesterday, indices in the APAC region were mostly positive with the Nikkei closing 1.34% higher and the ASX up 1.08%.
US and European futures are also trading positively.
The Irish Prime Minister said he is hopeful a Brexit free-trade deal can be made this week after warnings that time is running out.
Tesla’s shares will be added to the S&P 500 in one go on December 21st.
Moderna said its application for EUA in the US has been submitted.
Zoom reported its earnings showing sales rose over 350%, but its shares fell after-hours as there was a steady decline in gross margin.
Facebook has agreed on a deal to acquire CRM start-up, Kustomer in a $1 bn deal.
Salesforce, HP, Trip.com, Scotiabank and At Home are all set to report earnings today.
On the calendar today we have Eurozone PMI’s and inflation data, Canada’s GDP, and US ISM Manufacturing data. There are also speakers from the Bundesbank, ECB and Fed.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .